Awards & QUALIFICATIONS

• The Ruskell Medal, The Worshipful Company of Spectacle Makers, 2021
• The Founder's Cup, Oxford Ophthalmological Congress, 2018
• Fellow of the Royal College of Ophthalmologists, 2016
• MRC/Fight for Sight Clinical Research Training Fellowship, 2015
• Crombie Medal, Royal College of Ophthalmologists 2011
• BM BCh with Distinction, University of Oxford 2010
• MA (First Class), University of Cambridge 2007
• Swann Prize for Biology, Gonville & Caius College, Cambridge 2007
• Ian Gordon-Smith Prize for Medicine, Gonville & Caius College, Cambridge 2005

Harry's background is in Clinical Ophthalmology as a Specialist Registrar within the North London/Moorfields Eye Hospital training rotation. 

Harry's research focusses on developing a new gene-therapy based treatment for dominant retinitis pigmentosa (RP) caused by defects in the rhodopsin gene. These mutations account for around a quarter of all cases of dominant RP and are one of the most common genetic cause of sight loss in the UK.